CMPS vs MD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 30, 2026

CMPS

39.5
AI Score
VS
MD Wins

MD

62.1
AI Score

Investment Advisor Scores

CMPS

40score
Recommendation
AVOID NEW MONEY

MD

62score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CMPS MD Winner
Forward P/E 0 9.2937 Tie
PEG Ratio 0 0.2433 Tie
Revenue Growth 0.0% 4.0% MD
Earnings Growth 0.0% 6.5% MD
Tradestie Score 39.5/100 62.1/100 MD
Profit Margin 0.0% 9.0% MD
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD MD

Relative Price Performance (Last 90 Days)

CMPS 1M: -9.7% · 3M: -12.3% MD 1M: -2.7% · 3M: -3.7%

Current Technical Phase

CMPS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 35

RSI (14): 35.3 · Price: $11.95

MD

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 44.8 · Price: $25.76

Fundamentals Snapshot

Metric CMPS MD
Market Cap — —
Forward P/E -8.3 10.6
Trailing P/E — 12.5
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — 0.3%
Operating Margin 0.0% 0.1%
EPS -3.79 2.06
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.